跳至主要内容
临床试验/NCT02612493
NCT02612493已完成不适用

Obesity and Metabolic Surgery in Patients With Type I Diabetes

Sana Klinikum Offenbach0 个研究点目标入组 16 人开始时间: 2006年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
16
主要终点
Insulin dosage

研究概览

简要总结

Obesity is the indication for bariatric surgery in type I diabetes. Interestingly postsurgery the patients improve remarkable in their need for insulin, not only in the daily total insulin dosage but also in the dosage of IU per kg.

详细描述

The investigators performed a retrospective analysis on 16 patients undergoing weight loss surgery in obesity with concomitant type I diabetes. All patients were evaluated during Follow - Up to analyze insulin dosage and metabolic changes.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • type I diabetes
  • BMI > 40kg/m2

排除标准

  • type II diabetes

结局指标

主要结局

Insulin dosage

时间窗: up to 8 years

Insulin dosage postsurgery

次要结局

  • Change in lipids(up to 8 years)
  • Excess Weight loss in %(up to 8 years)
  • Change in HgA1c(up to 8 years)

研究者

发起方
Sana Klinikum Offenbach
申办方类型
Other
责任方
Principal Investigator
主要研究者

Christine Stier

MD, PhD

Sana Klinikum Offenbach

相似试验